Sort by
Refine Your Search
-
, and scholarly activities. In partnership with Northeastern University, CSL Seqirus is offering a two-year Medical Affairs fellowship, based in Waltham, Massachusetts. About CSL Seqirus At CSL Seqirus
-
, and scholarly activities. In partnership with Northeastern University, Vertex Pharmaceuticals is offering a two-year NA Commercial – US Market Access fellowship, based in Boston, MA. About Vertex Vertex
-
care worldwide. Through a phased training model, the program emphasizes both foundational knowledge and leadership development to prepare fellows for a successful career in the pharmaceutical industry
-
Commercial - US Market Access fellowship, based in Boston, MA. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with
-
, and teaching. In partnership with Northeastern University, Ironwood Pharmaceuticals is offering a two-year Clinical Development /Medical Scientific Affairs (CD/MSA) PharmD fellowship based in Boston
-
pharmacology and modeling strategies and building clinical pharmacology and pharmacometrics models to support dose selection at various stages of drug development. The Fellow will support the Clinical
-
applications and nominations for postdoctoral researchers based at Roux in Portland, Maine, USA. The selected researchers will be aligned with the AI for Climate and Sustainability (AI4CaS) focus area within
-
at Northeastern University invites applications for a Postdoctoral Research Associate or more senior position. The position is to begin Summer or Fall 2025 for a term of 2-3 years, with yearly renewals based upon
-
Affairs fellowship, based in Cambridge, MA. About Intellia Intellia Therapeutics is a biotechnology company focused on developing CRISPR-based gene editing therapies to transform lives of people with severe
-
Researcher will be based out of either the Boston, MA or Portland, ME campus and conduct applied research, prepare work for submission to journal/conference publications, contribute to extramural funding